Wockhardt hosted a visit at its Wrexham facility in North Wales of the Prime Minster of the UK, Boris Johnson.
The Prime Minister inspected the Wockhardt’s fill-finish production line and was accompanied by local Wrexham conservative MP Sarah Atherton.
The UK Government has reserved one fill and finish production line at Wockhardt UK for its exclusive use for 18 months in order to guarantee the supply of vaccines required to fight against COVID-19.
The PM said, “Today marks the next stage in the UK distribution of the coronavirus vaccine. Our agreement with Wockhardt is a significant milestone for the British life science industry and will help produce the vaccines this country needs. I am grateful to have met with some of the hardworking team here in Wales, who are helping take us one step closer to defeating this virus.” We have more than a billion dosage capacity for both API and fill-finish globally and can be a partner to fight the world’s most demanding need of the hour in COVID-19.”
Dr Habil Khorakiwala, Founder Chairman of Wockhardt said, “The visit by the Prime Minister of UK demonstrates our global strength in sterile injectable facilities and capacity. With four decades of expertise and experience behind us, we are able to quickly rise to the occasion, scale up the manufacture of much-desired vaccines and assist in mitigating the global impact of COVID-19.
In the UK, Wockhardt is a large supplier into the NHS for over 20 years and has had a presence in Wrexham for over two decades.
Ravi Limaye, MD, Wockhardt UK said, “We are privileged to host the Prime Minister and showcase our world-class manufacturing capability here in Wrexham. Our sophisticated sterile facility and highly skilled workforce are a prime example of why the manufacturing sector is a major employer accounting for around nine per cent of the UK workforce.”